FDA warns of eosinophilic pneumonia risk with Cubicin - ONA

Links shared publicly online about this topic.

  • 987
    total visits

FDA warns of eosinophilic pneumonia risk with Cubicin - ONA

oncologynurseadvisor.com

The FDA has notified healthcare professionals and patients about the potential for developing eosinophilic pneumonia while receiving the antibiotic Cubicin (daptomycin, from Cubist).

View full resource at oncologynurseadvisor.com

Tags: Pneumonia, Healthcare, FDA, Antibiotic

  • Share

Most Recently Shared on July 29, 2010 at 4:11 pm By:

ONAcom OncologyNurseAdvisor

FDA warns of eosinophilic pneumonia risk with Cubicin http://goo.gl/fb/EeN7V

2 years ago...

Eosinophilic Pneumonia Linked With Cubicin Use

medicalnewstoday.com — “FDA releases drug safety communication warning of potential to acquire this serious condition when receiving intravenous antibacterial daptomycin.Patients and health professionals haveView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on August 3, 2010 at 12:05 pm By:

The FDA warns about pneumonia caused by antibiotic Cubicin - latimes.com

latimes.com — “The Food and Drug Administration Thursday warned physicians and patients that the intravenous antibiotic Cubicin can cause life-threatening eosinophilic pneumonia, which is marked by the accumulation of a type of white blood cells called eosinophils in the lungs. Symptoms include fever, cough, shortness of breath and difficulty breathing.View full resource at latimes.com

  • View Related
  • Share

Most Recently Shared on July 31, 2010 at 6:20 pm By:

FDA warns about pneumonia risk linked to antibiotic Cubicin - Related Stories - ANA SmartBrief

smartbrief.com — “The FDA said patients treated with Cubist Pharmaceuticals' injectable antibiotic Cubicin might deveView full resource at smartbrief.com

  • View Related
  • Share

Most Recently Shared on July 30, 2010 at 5:22 pm By:

OklahomaNurses Oklahoma Nurses Health Organization

FDA warns about pneumonia risk linked to antibiotic Cubicin http://sbne.ws/r/5ggy #fb

2 years ago...

Cubicin Side Effects May Increase Pneumonia Risk: FDA - AboutLawsuits.com

aboutlawsuits.com — “Federal drug safety regulators are warning doctors and patients that the intravenous antibiotic Cubicin may increase the risk of pneumonia. On Thursday,View full resource at aboutlawsuits.com

  • View Related
  • Share

Most Recently Shared on July 30, 2010 at 2:32 pm By:

drgaidhane Monica R.Gaidhane Doctor and Physician

Cubicin Side Effects May Increase Pneumonia Risk: FDA - AboutLawsuits.com: http://bit.ly/dhpN2y via @addthis

2 years ago...

FDA MedWatch - Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia - Drugs.com MedNews

drugs.com — “ROCKVILLE, Md., July 29, 2010-ISSUE FDA notified healthcare professionals and patients about the potential for developing eosinophilic pneumonia during treatmenView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on July 30, 2010 at 11:39 am By:

Lung_Breathing Lungs and Breathing OW Health

FDA MedWatch - Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia: ROCKVILLE, Md., J... http://bit.ly/b9uuaB

2 years ago...

FDA Alert: Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia

drugs.com — “FDA Alert: Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic PneumoniaView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on July 30, 2010 at 2:34 am By:

drugscom Drugs.com Health Site

FDA Alert - FDA Warns of Eosinophilic Pneumonia Risk with Cubicin (daptomycin) - http://bit.ly/d3yDrx

2 years ago...

Medical News: FDA Finds Pneumonia Risk with Daptomycin - in Product Alert, Prescriptions from MedPage Today

medpagetoday.com — “The FDA said that the intravenous antibiotic daptomycin (Cubicin) may be linked to an increased risk of eosinophilic pneumonia -- a rare but serious potential side effect -- and requested that a new dView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on July 29, 2010 at 5:41 pm By:

medical_tweets medical_tweets Health News

FDA Finds Pneumonia Risk with Daptomycin (MedPage Today) -- The FDA said that the intravenous antibiotic daptomycin (Cu.. http://dld.bz/ppsG

2 years ago...

FDA warns of eosinophilic pneumonia risk with Cubicin - MPR

empr.com — “The FDA has notified healthcare professionals and patients about the potential for developing eosinophilic pneumonia while receiving the antibiotic Cubicin (daptomycin, from Cubist).View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on July 29, 2010 at 4:02 pm By:

eMPR MPR Medical Publisher

MPR News: FDA warns of eosinophilic pneumonia risk with Cubicin: The FDA has notified healthcare professionals and... http://bit.ly/9UDpdZ

2 years ago...

Advertisement